For someone who regularly needs insulin, hearing that a medicine is unavailable is more than an everyday inconvenience. Zhan Botanov knows this from personal experience. In September 2025, he reported that NovoRapid was unavailable at the pharmacy of Polyclinic No. 4 in Astana.
What situation was reported?
The publication dated 3 September 2025 concerned one pharmacy at a specific time. It was not a report of a citywide shortage and does not describe current stock levels.
Why document these incidents?
Uncertainty is particularly difficult when medication is needed regularly. Clear answers matter: why is the medicine not being supplied, has the appeal been registered, and what information can the responsible organisation provide?
Keeping the doctor’s treatment instructions, prescription details and written replies helps establish what happened. These documents make it easier to distinguish actual unavailability from problems with paperwork or collection.
What is known about the outcome?
There is no confirmed final response in this account that would support announcing the problem as resolved. The incident remains a documented part of Zhan Botanov’s experience and a reason to discuss access to medicines.
If you cannot obtain prescribed medication, explain your situation and attach the replies you have received. We can discuss which questions should be put to the responsible organisations.